.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Mallinckrodt
Boehringer Ingelheim
Queensland Health
Daiichi Sankyo
McKinsey
Cantor Fitzgerald
Cerilliant
Farmers Insurance

Generated: July 25, 2017

DrugPatentWatch Database Preview

Atenolol - Generic Drug Details

« Back to Dashboard

What are the generic sources for atenolol and what is the scope of atenolol patent protection?

Atenolol
is the generic ingredient in five branded drugs marketed by Zydus Pharms Usa, Pliva, Alvogen Malta, Able, Sun Pharm Inds Inc, Aurobindo Pharma, Teva, Apothecon, Teva Pharms, Sandoz, Mylan, Nostrum Labs, Dava Pharms Inc, Unique Pharm Labs, Watson Labs, Watson Labs Teva, Northstar Hlthcare, Astrazeneca, Sun Pharm Inds, SCS, Ipca Labs Ltd, and Mutual Pharm, and is included in forty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-three drug master file entries for atenolol. Fifty-eight suppliers are listed for this compound.

Summary for Generic Name: atenolol

Tradenames:5
Patents:1
Applicants:22
NDAs:44
Drug Master File Entries: see list33
Suppliers / Packagers: see list58
Bulk Api Vendors: see list95
Clinical Trials: see list96
Patent Applications: see list6,430
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:atenolol at DailyMed

Pharmacology for Ingredient: atenolol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pliva
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL074107-001Sep 24, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Scs
ATENOLOL
atenolol
TABLET;ORAL073676-001Oct 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
ATENOLOL
atenolol
TABLET;ORAL073315-001May 28, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa
ATENOLOL
atenolol
TABLET;ORAL076900-002Jan 28, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Dava Pharms Inc
ATENOLOL
atenolol
TABLET;ORAL073542-001Dec 19, 1991ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: atenolol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-004Apr 9, 1990► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Federal Trade Commission
Fish and Richardson
Cipla
Express Scripts
Queensland Health
UBS
McKesson
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot